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Abstract
Background: Postprandial non-esterified fatty acid (NEFA) and triglyceride (TG) responses are increased in subjects
with type 2 diabetes mellitus (T2DM) and may impair insulin action and increase risk of cardiovascular disease and
death. Dietary carbohydrate reduction has been suggested as non-pharmacological therapy for T2DM, but the
acute effects on NEFA and TG during subsequent meals remain to be investigated.
Methods: Postprandial NEFA and TG responses were assessed in subjects with T2DM by comparing a
carbohydrate-reduced high-protein (CRHP) diet with a conventional diabetes (CD) diet in an open-label,
randomized, cross-over study. Each diet was consumed on two consecutive days, separated by a wash-out period.
The iso-caloric CRHP/CD diets contained 31/54 E% from carbohydrate, 29/16 E% energy from protein and 40/30 E%
from fat, respectively. Sixteen subjects with well-controlled T2DM (median HbA1c 47 mmol/mol, (37–67 mmol/mol)
and BMI 30 ± 4.4 kg/m2) participated in the study. NEFA and TG were evaluated following breakfast and lunch.
Results: NEFA net area under curve (AUC) was increased by 97 ± 38 μmol/Lx270 min (p = 0.024) after breakfast but
reduced by 141 ± 33 μmol/Lx180 min (p < 0.001) after lunch on the CRHP compared with CD diet. Likewise, TG net
AUC was increased by 80 ± 28 μmol/Lx270 min (p = 0.012) after breakfast but reduced by 320 ± 60 μmol/Lx180 min
(p < 0.001) after lunch on the CRHP compared with CD diet.
Conclusions: In well-controlled T2DM a modest reduction of dietary carbohydrate with a corresponding increase in
protein and fat acutely reduced postprandial serum NEFA suppression and increased serum TG responses after a
breakfast meal but had the opposite effect after a lunch meal. The mechanism behind this second-meal
phenomenon of CRHP diet on important risk factors for aggravating T2DM and cardiovascular disease awaits further
investigation.
Trial registration: The study was registered at clinicaltrials.gov ID: NCT02472951. https://clinicaltrials.gov/ct2/show/
NCT02472951. Registered June 16, 2015.
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Background
Non-esterified fatty acids (NEFAs) and triglycerides are
present in the circulation in varying quantities dependent
on food - and body composition, insulin resistance and
glucose tolerance [1–3]. In T2DM, the adipocytes are in-
sulin resistant, leading to a reduced anti-lipolytic effect of
insulin and elevated levels of circulating NEFA especially
postprandially [4]. The elevated postprandial release of
NEFA has been associated with cardiovascular mortality
[5] and development of type 2 diabetes mellitus (T2DM)
[6, 7]. Enhanced postprandial triglyceridemia is a distinct
component of the diabetic dyslipidemia [8] and is an inde-
pendent strong predictor of ischemic heart disease [9].
In T2DM, dietary management with concomitant body
weight loss is suggested to be the basis of prevention
and treatment to reduce comorbidities such as cardio-
vascular disease [10, 11].
On the other hand, it is well-known that long-term
weight loss is very difficult to obtain and another treat-
ment strategy to improve glycemic control may be to
change the quality of food recommended to patients
with type 2 diabetes [12, 13]. Although the most recent
consensus guideline has made no specific recommenda-
tions on the macronutrient composition [14], the Dia-
betes Nutrition Study Group under European
Association for the Study of Diabetes stated in 2004
that the reason for recommending a moderately high
carbohydrate diet was the recommendation of 15E%
protein and 30E% fat, leaving 55E% for carbohydrate
[15]. In diets low in carbohydrate the protein as well as the
fat content is higher than in the recommended diabetes
diet. The higher content of fat in carbohydrate-reduced di-
ets could in theory induce higher postprandial concentra-
tions of NEFA and triglycerides (TG).
The aim of the present study was to compare a
carbohydrate-reduced high-protein (CRHP) and high fat
diet with an iso-energetically conventional diabetes (CD)
diet in relation to postprandial NEFA and TG excursions
in subjects with T2DM.
Methods
Study design
The study design has been described in detail elsewhere
[16]. In short, the participants underwent two separate
48-h interventions in a randomized, crossover design, with
a 2–8 weeks washout period between each intervention.
Participants were randomized to start with either a CRHP
or CD diet by drawing blinded ballots, and were provided
with their assigned diets, comprising breakfast, lunch,
pre-dinner snack, dinner and post-dinner snack, for two
consecutive days. Participants attended the Endocrine Re-
search Unit, University of Copenhagen, Bispebjerg Hos-
pital, Denmark, where mixed meal tests (MMT) were
performed at breakfast and lunch on both days for each
diet. After an overnight fast and voiding the bladder, pa-
tients were weighed, and a venous catheter was placed in
an antecubital vein to draw blood samples at times − 10,
0, 10, 20, 30, 45, 60, 90, 120, 150, 180, 210, 240, 270, 280,
290, 300, 315, 330, 360, 390, 420 and 450min (min). The
breakfast provided 30% of daily total energy expenditure
(TEE) and was served at time 0min and consumed within
30min. Likewise the lunch meal comprised 30% of TEE
and was served at time 270min and consumed within 30
min. The participants rested in a reclined position and
remained sedentary throughout breakfast and lunch
MMT. Dinner (30% of TEE) and snacks (10% of TEE)
were provided for later consumption at home. TEE was
estimated based on dual-energy X-ray absorptiometry
(Lunar iDXA, GE Healthcare) prior to interventions, as
described in detail elsewhere [16]. All ingredients were
weighed out by the hospital research kitchen. A standard-
ized isocaloric dinner (macronutrient content: 54% of en-
ergy from carbohydrates, 16% from protein and 30% from
fat) was provided for the evening meal prior to each 48-h
intervention period. Participants were asked to refrain
from alcohol and strenuous physical activity for 3 days
prior to each experimental period, and coffee or tea was
not allowed during the intervention days.
Participants
Sixteen participants with well-controlled T2DM in met-
formin mono-therapy were included in the study
(Table 1). All participants were non-smokers and were
weight stable throughout the study. Ten participants
were treated with statins. Lipid lowering agents were
kept unchanged throughout the study. Diagnosis of
T2DM was based on the American Diabetes Association
criteria [17].
Table 1 Baseline characteristics of participants, n = 16
Characteristics Values (mean ± SD)
N 16
Gender (male / female) 14 / 2
Lipid lowering medication (statins / no therapy) 10 / 6
Age (y) 62 ± 6.9
Diabetes duration (y) 6.6 ± 4.6
Body weight (kg) 94 ± 17
BMI (kg/m2) 30 ± 4.4
HbA1c (mmol/mol) 50 ± 9.2
Fasting plasma glucose (mmol/L) 8.2 ± 2.0
Fat mass (kg) 32 ± 9.2
Fat free mass (kg) 62 ± 10
TEE1 (MJ/day) 10 ± 1.4
HOMA2-IR2 2.4 ± 1.0
1Total energy expenditure
2HOMA2 Calculator Version 2.2.3, University of Oxford
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Written informed consent was obtained from all partici-
pants prior to any study related procedures. The study
protocol was approved by the Health Ethics Committee of
Copenhagen in accordance with the Helsinki-II declar-
ation, and the trial was registered at clinicaltrials.gov (ID:
NCT02472951). No participants dropped out of the study.
Diet compositions
A CRHP diet (macronutrient composition: 31% of energy
from carbohydrates, 29% from protein and 40% from fat)
was compared with a CD diet (macronutrient compos-
ition: 54% of energy from carbohydrates, 16% from pro-
tein and 30% from fat) composed in accordance with the
recommended diet for T2DM [15]. Full details on ingredi-
ents in the diets have been published elsewhere [16].
Analytical procedures
The first 2 mL of each blood sample drawn were dis-
carded, after which blood was collected in clot activator
tubes that were left for 30min before centrifugation to
obtain serum. Separate samples, taken into smaller
EDTA-containing tubes were centrifuged immediately for
measurement of plasma glucose (PG) using YSI 2300
STAT plus (Yellow Spring Instruments, Yellow Springs,
OH, USA). Serum NEFA was analyzed using a commer-
cially available reagent (Wako, NEFA-HR [2], Wako Che-
micals GmbH, Neuss, Germany) with the ACS-ACOD
Method [18, 19], providing CV < 1.5% at all NEFA concen-
trations. Serum TG was analyzed by enzymatic colorimet-
ric analysis by using the Cobas 8000 modular analyzer
(Roche Diagnostics, Indianapolis, IN, USA) standardized
against isotope dilution-mass spectrometry, providing CV
of 1.4% at 2.12mmol/L. Cortisol was measured in plasma,
obtained in EDTA-tubes centrifuged at 4 degrees Celsius
after sampling, by use of the Immulite 2000 Cortisol Sys-
tems Analyzer (Siemens Healthcare).
Calculations and statistics
Area under curve (AUC) was calculated using the trap-
ezoidal rule and net AUC was calculated by subtracting
the AUC below baseline values. Values are expressed as
means ± SEM. Fasting concentrations (baseline) were
calculated as means of the − 10 and 0min samples for
breakfast and baseline level as the 270-min sample for
lunch (initiation of lunch). To evaluate statistical differ-
ences between diets, means of both consecutive days on
each diet were compared using Student’s t tests or Wil-
coxon signed-rank test as appropriate. Graphical evalu-
ation was used to evaluate Gaussian distribution. To
evaluate differences in serum NEFA and TG concentra-
tions at individual time points, two-way repeated mea-
sures ANOVA was used on means of both consecutive
days, with subjects as fixed effects and treatment and time
as repeated measures. Bonferroni’s multiple comparison
adjustment of significance levels was made on individual
time points as post hoc comparisons to adjust for multiple
comparisons. Correlation was evaluated with Pearson or
Spearman correlation as appropriate. Significance level
was set at p-values below 0.05. With n = 16 participants
an estimated effect size between diets of 11% (SD = 15%)
was calculated to be found, provided a power of 80% at
significance p < 0.05. GraphPad Prism (version 7.02;
Graphpad Software, CA, USA) was used for statistical
analyses.
Results
Glucose and insulin data have been previously published
[16]. Essentially, postprandial glucose and insulin AUC
were reduced by 14 and 22% (both p < 0.001), respect-
ively, by the CRHP compared with the CD diet. Second-
ary analyses on previously published insulin data were
performed for the present study with permission from
British Journal of Nutrition.
NEFA
Fasting NEFA concentrations did not differ on the two diets
(Fig. 1). During breakfast, suppression of NEFA was more
pronounced on CD resulting in a less total AUC of NEFA
compared with CRHP diet (Fig. 1, Table 2). Nadir NEFA
concentration was increased by 26% (354 ± 34.4 vs. 282 ±
31.7 μmol/L, p = 0.012) and time to nadir was decreased
(114 ± 19.4 vs. 163 ± 11.0min, p = 0.041), respectively, by
the CRHP compared with CD diet (Fig. 1, Table 2). Net
NEFA AUC was significantly greater with CRHP (− 201 ±
38 vs. − 298 ± 48 μmol/L × 270min (p = 0.024)) compared
with CD diet.
Before start of lunch (270min) baseline NEFA concen-
tration was significantly higher after CRHP compared with
CD diet (Fig. 1). The pattern of NEFA concentrations dur-
ing lunch differ between the two diets with a significant
increase in NEFA during CD, while a significant reduction
in NEFA was observed during CRHP diet. Total AUC of
NEFA during the lunch did not differ, while net AUC from
baseline (88 ± 31 vs. -53 ± 27 μmol/ × 180min, p < 0.001)
was significantly less after CRHP compared with CD diet
(Fig. 1, Table 2). At end of lunch the NEFA concentrations
did not differ between the two diets.
During both meals total AUC NEFA was significantly
enhanced by 13% (56 ± 16 μmol/L × 450 min, p = 0.003)
with CRHP compared with CD (Table 2).
As a measure of within-subject variability, a strong
correlation was found between fasting NEFA concentra-
tions on each diet (Pearson r = 0.80, p < 0.001). No cor-
relation was found between NEFA concentration at 270
min (initiation of lunch) and the increase of glucose [16]
after ingestion of lunch on either diet (Pearson r = −
0.126 CD diet and r = − 0.180 CRHP diet, both p > 0.5),
data not shown. A borderline significant correlation was
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found between fasting cortisol and fasting NEFA con-
centrations (Pearson r = 0.245, p = 0.051).
Triglyceride.
Fasting TG on the CD vs. CRHP diet did not differ
(1.86 (IQR 1.55;2.44) vs. 1.72 (IQR 1.40;2.07), P > 0.05).
Peak serum TG concentrations were reached 270 min
after breakfast on both diets. The increase in serum TG
was enhanced after ingestion of CRHP compared with
CD diet, resulting in a tendency to a higher total AUC
TG and a significantly greater net AUC TG 0.44 ± 0.04
vs. 0.36 ± 0.05 mmol/L × 270 min (p = 0.012), respectively
(Fig. 2, Table 2). Incremental TG values are presented in
Fig. 2. At 270min the TG concentration was significantly
higher during CRHP compared with CD diet (Fig. 2).
After Lunch the changes in TG concentrations parallel
the changes in NEFA with an increase during CD and a
significant reduction in TG after CRHP diet (Fig. 2),
resulting in a net AUC of − 0.08 ± 0.05 vs. 0.24 ± 0.06
mmol/L × 180min (p < 0.001), respectively (Fig. 2).
Lunch total AUC TG tended to be high at CD compared
with CRHP diet (Table 2, p = 0.065).
During both meals total AUC TG did not differ signifi-
cantly (Table 2, p = 0.12).
As a measure of within-subject variability, a strong
correlation was found between fasting TG concentra-
tions on each diet (Spearman r = 0.82, p < 0.001).
Insulin
Fasting insulin concentrations did not differ between the
two diets (Fig. 3). The CRHP diet reduced postprandial
insulin responses after both the breakfast and lunch
meals as compared with the CD diet (Fig. 3, Table 2), as
peak insulin concentrations were reduced following both
breakfast (334 ± 44.5 vs. 440 ± 53.6 pmol/L, p = 0.032)
and lunch (372 ± 41.9 vs. 417 ± 41.2, p = 0.043) and net
insulin AUC was reduced by 32% (153 ± 17 vs. 224 ± 23
pmol/L × 270min, p < 0.001) following breakfast and by
53% (80 ± 18 vs. 171 ± 23 pmol/L × 180 min, p = 0.003)
following lunch. Postprandial excursions of insulin were
similar following breakfast and lunch within each diet,
as no differences were found between the insulin peaks
on the CRHP breakfast compared with CRHP lunch
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Fig. 1 Concentration of non-esterified fatty acid (NEFA) in sixteen well-controlled patients with type 2 diabetes after intake of a carbohydrate-
reduced high-protein (CRHP) or conventional diabetes (CD) breakfast (0–270min) and lunch (270–450min), respectively (means of 2 consecutive
days on each diet). Values are presented as means with their standard errors. Bar charts show net area under curve for breakfast and lunch,
respectively. *Significant difference (p < 0.05) between diets
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(p = 0.42) or on the CD breakfast compared with CD
lunch (p = 0.82).
A correlation was found between fasting insulin and
fasting TG concentrations (Pearson r = 0.311, p = 0.013),
while no correlation was found between fasting insulin and
fasting NEFA concentrations (Pearson r = 0.065, p = 0.61).
Discussion
The present study showed, in well-controlled T2DM,
that a modest reduction of dietary carbohydrate content
with a corresponding increase in protein and fat content
compared with an energy-matched conventionally dia-
betes diet acutely reduced postprandial serum NEFA
suppression and increased serum TG responses after a
breakfast meal but had the opposite effect after a lunch
meal. We previously reported in the same subjects that
the reduced carbohydrate intake exerted a marked acute
beneficial effect on glucose excursions despite reduced
insulin secretion [16].
Elevated fasting concentration of NEFA has been
shown to be proportional to body fat storage [20],
and reflects insulin resistance in adipose tissue and
is a predictor of subsequent development of T2DM
[6, 21].
In the fasting state, NEFA is released to the circulation
by lipolysis in adipose tissue, primarily from subcutane-
ous adipose tissue, but as obesity progresses, visceral
adipose tissue contributes relatively more to the NEFA
pool [22]. The circulating NEFA pool provides energy
substrates for tissues, with fasting circulating NEFA con-
centrations being regulated by hormones with diurnal
variations such as cortisol, catecholamines and insulin
[23–25]. In the present study, a borderline significant
correlation was found between fasting cortisol and fast-
ing NEFA concentrations.
In the fed state, insulin suppresses lipolysis and in-
creases re-esterification of fatty acids [26, 27]. In the
present study, circulating NEFA concentrations were
suppressed to a smaller extent by the CRHP breakfast
than by the CD breakfast, likely to be explained by the
observed reduction in the postprandial insulin excursion
following the CRHP diet (Fig. 3, Table 2).
An inverse response in NEFA concentrations was
found after lunch, despite similar insulin concentrations
following breakfast and lunch following each diet. Thus,
a reduction of net NEFA AUC was found following the
CRHP lunch compared with a net increase following the
CD lunch. This paradoxical shift may be explained by
the excursions of TG and a possible increase in
Table 2 Postprandial NEFA, triglyceride and insulin and fasting cortisol in subjects with type 2 diabetes, N = 16
CD diet CRHP diet p-
value*mean SEM mean SEM
NEFA responses
Total AUC (μmol/L × 450min) 432 35 488 34 0.003
Breakfast AUC (μmol/L × 270min) 393 33 477 32 < 0.001
Breakfast net AUC (μmol/L × 270min) -298 48 -201 38 0.024
Lunch AUC (μmol/L × 180min) 491 49 505 48 0.52
Lunch net AUC (μmol/L × 180min) 88 31 −53 27 < 0.001
Triglyceride responses
Total AUC (mmol/L × 450min) 2.65 0.29 2.35 0.17 0.12
Breakfast AUC (mmol/L × 270min) 2.43 0.26 2.21 0.16 0.20
Breakfast net AUC (mmol/L × 270min) 0.36 0.05 0.44 0.04 0.012
Lunch AUC (mmol/L × 180 min) 2.97 0.33 2.57 0.21 0.065
Lunch net AUC (mmol/L × 180min) 0.24 0.06 −0.08 0.05 < 0.001
Insulin responses
Total AUC (pmol/L × 450min) 342 36 266 31 < 0.001
Breakfast AUC (pmol/L × 270min) 325 37 259 31 < 0.001
Breakfast net AUC (pmol/L × 270min) 224 23 153 17 < 0.001
Lunch AUC (pmol/L × 180min) 367 36 278 34 0.005
Lunch net AUC (pmol/L × 180min) 171 23 80 18 0.003
Cortisol
Fasting concentration (nmol/L) 380 26 371 34 0.71
Abbreviations: NEFA, non-esterified fatty acids; CD, conventional diabetes; CRHP carbohydrate-reduced high-protein; AUC, area under curve; *using Student’s paired t-test
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lipo-protein lipase (LPL) activity facilitated by the in-
crease in insulin [23]. Lipo-protein lipase is induced by
insulin after a delay and hydrolyses TG from lipopro-
teins at the capillary endothelial luminal surface, where
some, but not all, of the NEFA is taken up by the tissue.
A fraction of of this NEFA escapes uptake and is spilled
over back to the circulating NEFA pool [28–31]. We
previously reported this paradoxical difference in NEFA
response to breakfast and lunch in non-diabetic subjects
[32]. As elevated serum NEFA concentrations can impair
peripheral glucose uptake by inhibition of insulin-stimu-
lated glucose disposal [33–35], an enhanced or reduced
postprandial NEFA response may modulate postprandial
glucose responses [34].
The TG excursion was increased following the CRHP
breakfast, but reduced following lunch, compared with
the CD diet. Thus, the second meal elicited the opposite
effect on TG concentrations after the CRHP lunch com-
pared with breakfast even though the fat content was
higher in the CRHP diet. Again, the decrease in postpran-
dial insulin response following the CRHP, compared with
CD, diet (Fig. 3, Table 2) adds to the explanation of this
variation. Chen et al. found a high-carbohydrate diet
(55E%) to increase production of very low density
lipo-protein triglyceride (VLDL-TG) in the liver of subjects
with type 2 diabetes, secondary to a higher insulin concen-
tration [36]. Both de novo lipogenesis and fatty acid
re-esterification contribute to the production of VLDL-TG
[37]. Chylomicron-derived TG is cleared competitively
through the same pathways as VLDL-TG produced in the
liver, thus explaining the net result of elevated plasma TG
on higher, compared with lower, carbohydrate diets found
in previous studies [36, 38–40]. This finding is only appar-
ent in the subsequent meal after breakfast in the present
study, which underscores the need to employ consecutive
meals to evaluate dietary effects on lipid metabolism. Thus,
interpretation of NEFA and TG excursions following a sin-
gle meal may be confounded by the delayed effects of insu-
lin on lipid metabolism. Furthermore, postprandial NEFA
excursions should be evaluated in concert with TG excur-
sions, as the circulating concentrations of these substrates
are highly interdependent.
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Fig. 2 Incremental concentration of triglyceride in sixteen well-controlled patients with type 2 diabetes after intake of a carbohydrate-reduced
high-protein (CRHP) or conventional diabetes (CD) breakfast (0–270min) and lunch (270–450min), respectively (means of 2 consecutive days on
each diet). Values are presented as means with their standard errors. Bar charts show net area under curve for breakfast and lunch, respectively.
*Significant difference (p < 0.05) between diets
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Within-subject variability of fasting and postprandial
NEFA concentrations is substantial (CV 24–45%) [41, 42],
and even short term (30 days) within-subject concentra-
tions of two fasting NEFA measurements only show a cor-
relation coefficient (r) of 0.70 (p < 0.001) [43], complicating
use and interpretation of fasting NEFA levels. Therefore, it
is crucial to employ rigorous protocols to assure
standardization between interventions, e.g. equal durations
of overnight fast, identical dinners prior to intervention
days etc.
A strength of the present study was the thoroughly
standardized protocol, designed to minimize within-sub-
ject variability between interventions, resulting in a
stronger within-subject correlation (Pearson r = 0.80, p <
0.001) in fasting NEFA concentrations than previously
reported. A further strength is the measurement of post-
prandial NEFA and TG responses to two subsequent
meals, because, as was found, the response to a second
meal can differ from the response to the first meal. Im-
portantly, all meals were provided to the patients and
the two diets were energy-matched to ensure a highly
controlled setting.
Conclusions
In well-controlled T2DM patients, intake of an ex-
perimental diet moderately reduced in carbohydrate
and increased in protein and fat content acutely re-
duced postprandial serum NEFA suppression and in-
creased serum TG responses after a breakfast meal
but had the opposite effect after a lunch meal when
compared with the recommended diet for diabetes
patients. Studies are needed to evaluate these effects
in longer term studies and in subjects with more dys-
regulated diabetes.
Abbreviations
AUC: area under curve; CD: conventional diabetes; CRHP: carbohydrate-
reduced high-protein; LPL: lipoprotein lipase; MMT: mixed meal test;
NEFA: non-esterified fatty acids; PG: plasma glucose; T2DM: type 2 diabetes
mellitus; TEE: total energy expenditure; TG: triglyceride
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